GRI Bio, Inc. GRI

2.05 (0.04) (1.91%) as of 25 Sep
Market cap
$4.6M
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
P/E ratio
— — — — — 0.00 — — —
P/S ratio
— — — — — 0.00 — — —
P/FCF ratio
— — — — — 0.00 — — —
P/Operating CF
— — — — — (54,496,333.59) — — —
P/B ratio
— — — — — 0.00 — — —
EV/Sales
— — — — — 0.00 — — —
EV/EBITDA
— — — — — 0.00 — — —
EV/FCF
— — — — — (11,875,144.94) — — —
Current Ratio
3.25 3.43 1.09 0.16 3.32 0.30 4.85 1.31 —
Net Debt/EBITDA
0.69 0.61 0.19 0.00 0.81 0.02 1.21 0.14 —
Debt/Equity
0.00 0.00 0.00 0.00 0.01 (0.01) 0.08 0.00 —
ROE
(238.17%) (471.59%) 1,908.78% (153.45%) (426.35%) (547.95%) (205.77%) (256.19%) —
ROA
(166.00%) (232.73%) (780.89%) (73.80%) (200.28%) (184.36%) (140.95%) (1,349.37%) —
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% —
Return on Tangible Assets
(200.87%) (254.03%) (5,321.22%) 191.72% (157.95%) 311.30% (111.20%) (2,820.54%) —
Average Days of Receivables
— — — — — 0.00 — — —
Earnings Yield
— — — — — 0.00% — — —
Free Cash Flow Yield
— — — — — 0.00% — — —
Free Cash Flow per Share
(103.76) (1,324.77) (89,980.00) 0.00 (1.27) (0.82) (0.81) (10.44) —
Book value per Share
61.18 620.31 2,590.00 0.00 0.89 (0.32) 0.91 0.67 —
Free Cash Flow
(10.19) (8.61) (9.00) (1.09) (8.31) (3.71) (2.88) (2.37) —
EV/EBIT
— — — — — 0.00 — — —
Other line items

Show all line items

Columns are period end dates